|
Welcome to the second issue of Connections, an
exciting new way for AFA members to connect with each other
and with professionals
from around the world for support and information. This month's
Connections newsletter includes an article from a featured professional,
Dr. Jessica R. Brown, and dates and times of weekly online educational
meetings during February.
In this month's Connections newsletter, The AFA would also like to address an article, "Is This Any
Way to Have a Baby?”,
published in the February issue of O Magazine (Oprah's
magazine). This article consists primarily of anecdotes from
former infertility
patients who either failed to become pregnant or had serious
health issues during or following their infertility treatment.
In The AFA's view, this article was not well-researched and
made sweeping generalities without reliable evidence to back
them
up. The AFA agrees with professional organizations like the
American Society for Reproductive Medicine in insisting that
this article
made no sincere effort to provide objectivity or to distinguish
underlying medical problems that may be associated with but
not caused by the infertility treatment. If you’d like
to read additional rebuttals to the article’s claims,
please visit this link.
Patients
often feel victimized by and angry about their infertility
condition, particularly when treatments fail or are associated
with physical and emotional discomfort. Rather than providing
useful, factual information, "Is This Any Way to Have
a Baby?" merely serves to mislead and frighten already
vulnerable women and undermine their trust in their healthcare
providers. This type of fear-driven journalism does not support
women or patients.
We look to Oprah and O
Magazine for reliable information.
As a leading patient advocate for the infertile and one-time
guest on her talk show, I find that this article does not reflect
the Oprah standard that so many have come to expect.
I welcome
hearing your thoughts and concerns, and I hope you’ll
join The AFA this month for more exciting Connections online
educational events. Sincerely,
Pamela Madsen
Executive Director, The American Fertility Association
|

Connections
Online
Sessions Schedule - February
February
4, 2004, Wednesday
Speaker: Benjamin Sandler, M.D. (Reproductive Medicine Associates of New York)
Topic: Blastocysts? Grading? How to Make Sense Out of the Language….
Time: 8-9 PM, EST (DST)
February
11, 2004, Wednesday
Speaker: Kaylen Silverberg, M.D. (Texas Fertility Center)
Topic: Surgical Procedures: What They Are and When They’re Necessary
Time: 8-9 PM, EST (DST)
February
17, 2004, Tuesday
Speaker: David Hoffman, M.D. (IVF Florida Reproductive Associates)
Topic: IVF Explained
Time: 8-9 PM, EST (DST)
February 24, 2004, Tuesday
Speaker: Peter Schlegel, M.D. (Cornell Institute for Reproductive Medicine;
Center for Male Reproductive Medicine and Microsurgery)
Topic: When Male Factor is Part of Your Diagnosis
Time: 8-9 PM, EST (DST)
Click here for Connections Online
|
Jessica
R. Brown, MD
Reproductive Medicine Associates of Brooklyn, LLP
A Satellite Office of NYU Medical Center, Program
for IVF, Reproductive Surgery and Infertility
Clinical Assistant Professor
of Obstetrics and Gynecology
NYU School of Medicine
UNEXPLAINED
INFERTILITY
When
a standard evaluation fails to reveal any abnormalities infertility
is said to be “unexplained.” More than anything,
those suffering from infertility desire children. But the
desire to understand the reason for infertility can also
be powerful. Those with a diagnosis of “unexplained
infertility” suffer the added frustration of not knowing
why they have been unable to conceive. Fortunately, many
of those with unexplained infertility do eventually conceive,
both with and without treatment. Which diagnostic tests are
essential, and when can additional testing be beneficial?
When is it time to move from diagnostic testing to treatment,
and which treatments can be effective even when the cause
of infertility remains a mystery? A thorough understanding
of infertility testing and treatment options will help you
to chart your own best course of action.
Causes
of infertility/subfertility
About
15% of cases on infertility are unexplained. Well-recognized
causes of infertility (inability to conceive) include failure
to ovulate, absence of sperm, or complete tubal obstruction.
Thus, a standard infertility evaluation includes testing
to document ovulation, semen analysis, and a hysterosalpingogram
to evaluate tubal patency. In many cases, what we call “infertility” is
actually “subfertility”. Subfertile couples may
be able to conceive, but they take longer to do so. Causes
of subfertility include such varied conditions as advanced
female age, infrequent ovulation (oligoovulation), luteal
phase defect (inadequate progesterone production after ovulation),
endometriosis, partial tubal obstruction, poor semen quality—such
as low count, motility, and morphology (shape), abnormal
(“hostile”) cervical mucus, and infections of
the genital tract. Other conditions, such as uterine myomata
(fibroids), are commonly seen in fertile women but are clearly
responsible for infertility in some cases. Stress is also
commonly implicated in infertility. Extreme stress can cause
complete cessation of ovulation and menstruation, but the
role of “everyday” stress is less clear. Some
have conceived after utilizing techniques such as “mind/body” programs
to help deal with stress.
The
problem of “old eggs”
It
is now recognized that many cases of subfertility can be
attributed to “decreased ovarian reserve,” a
term which describes the decreased capacity of the aging
ovary to produce a healthy egg and a viable pregnancy. In
fertile women, the average age of last birth is
41. Looked at another way, at least half of normal, fertile
women will be infertile if they try to conceive at age 41
or over, and many will be infertile even at slightly younger
ages. Decreased ovarian reserve is a normal phenomenon in
older reproductive-aged women, who are typically subfertile.
Many younger women who had been thought to have unexplained
infertility will also be found to have decreased ovarian
reserve. In one study, 38% of women with unexplained infertility
actually had decreased ovarian reserve.
The
easiest way to measure ovarian reserve is to draw blood during
menstruation, usually on day 2 or 3, and measure levels of
FSH and estradiol. High FSH levels, and, to a lesser extent,
high estradiol levels, signify decreased ovarian reserve
and a decreased fertility potential. More sophisticated tests,
such as the “Clomid challenge,” are even more
sensitive, revealing that some women with normal levels of
FSH and estradiol on day 3 actually have decreased ovarian
reserve. But it is important to remember that some women
with decreased ovarian reserve do still get pregnant. Both
increasing age and increasing FSH independently correlate
with decreased fertility potential. While the prognosis for “older” (over
40) women with high FSH is indeed quite poor, younger women
with high FSH should be advised to consider aggressive treatment
early on in order to maximize their fertility potential with
their own eggs. Great care must be taken in interpreting
FSH levels, since the normal range varies greatly from lab
to lab, as does the reliability of the test for predicting
subsequent fertility.
Fertility
rates in unexplained infertility
Studies
show that when couples with unexplained infertility are followed
for three more years 40-60% conceive on their own. The chance
of conceiving is about 3% per cycle, far less than the normal
cycle fecundity of about 20% in fertile couples. Unfortunately,
no test exists to distinguish those couples who will conceive
on their own from those who will still be childless three
years later. Counseling for unexplained infertility should
include assuring properly timed intercourse to maximize natural
fertility potential. Periodic reevaluation is also important
since problems that might benefit from specific treatment
may develop over time. Without any “fertility crystal
ball” to guide us, the age of the female partner remains
the most important factor guiding the decision between watchful
waiting and aggressive treatment. Younger women (in their
20s) who have normal ovarian reserve may have the luxury
of time, since pregnancy rates with more aggressive treatments
such as in vitro fertilization (IVF) remain high through
the early 30s. Consideration of a woman’s current age
and the magnitude of the drop in pregnancy rates with IVF
over the next two to three years will help determine for
how long a particular couple feels comfortable trying “on
their own.” IVF pregnancy rates for couples with unexplained
infertility are comparable to those for couples doing IVF
for other reasons.
Why
can’t we conceive?
How
can you solve a problem if you don’t know what the
problem is? Until recently, those with unexplained infertility
typically spent a good deal of time and money undergoing
extensive testing in search of “the cause.” With
unexplained infertility, it is possible to overcome the infertility
despite a lack of understanding of its causation (see below).
But when the cause of infertility is known, treatment options
also include targeted therapies aimed at overcoming a specific
problem. For example, men who test positive for antisperm
antibodies can be treated with immunosuppressive drugs, and
couples with abnormal post-coital tests can be treated specifically
with agents to improve cervical mucus quality. Until recently,
women with infertility routinely underwent laparoscopy to
detect conditions which could be treated surgically, such
as endometriosis or pelvic adhesions. And many couples also
routinely underwent more sophisticated laboratory testing,
such as the sperm penetration assay (hamster test) and the
hemizona assay, to more thoroughly assess sperm function.
But since intracytoplasmic sperm injection (ICSI) now enables
fertilization to occur in nearly all cases, the usefulness
of these sperm function tests has been vastly diminished.
So
when do you stop testing and begin treatment? For each recommended
test you should ask “how will the result of this test
affect my treatment options?” For women of older reproductive
age it is generally unwise to delay the initiation of treatment
by pursuing additional testing. On the other hand, younger
women with unexplained infertility who would prefer to avoid
IVF if possible are good candidates for a more thorough evaluation.
The information derived from additional testing can sometimes
suggest simpler, less expensive treatment options that may
be effective.
How
can we conceive?
Those
with unexplained infertility must decide whether to continue
the search for a cause or pursue “empiric” treatment
(treatment which can boost the odds of conception whether
or not the “cause” is ever found). Controlled
ovarian hyperstimulation (giving fertility drugs to induce
the ovulation of more than one egg per cycle) is most effective
if combined with timed intrauterine insemination (IUI—the
injection of washed sperm directly into the uterus). Fertility
drugs can be given by mouth (clomiphene citrate) or by injection
of either [1] human menopausal gonadotropins (HMG), a mixture
of follicle stimulating hormone (FSH) and luteinizing hormone
(LH) which is purified from postmenopausal women’s
urine or [2] pure FSH, which is now generally a recombinant
product, synthesized via genetic engineering).
Clomiphene
with IUI is associated with few serious side effects but
also lower pregnancy rates (no more than about 9% per cycle
or 25% at three-to-four months).Women being treated with
injectable fertility drugs must be monitored very closely
to help avoid the risks of multiple birth and ovarian hyperstimulation
syndrome, but pregnancy rates can be up to two to three times
as high as with clomiphene. The highest pregnancy rates per
cycle (about 30% nationwide for 1999, and as much as 50%
per cycle for younger women in some programs) are seen with
assisted reproductive technologies such as in vitro fertilization
(IVF). IVF also provides information about fertilization
rates and embryo development that can help explain the previously “unexplained.” For
example, women may prove to be “poor responders” to
fertility drugs despite previously normal testing for ovarian
reserve. In other cases, embryos develop too slowly or are
of poor quality, both of which correlate with decreased pregnancy
rates. In rare cases, complete fertilization failure occurs
despite normal appearing sperm and eggs. ICSI, a technique
developed to achieve fertilization despite extremely poor
semen quality, can also be effective in these cases, although
interestingly, a majority of these couples will see fertilization
occur “naturally” in subsequent cycles. Because
ICSI is so effective in overcoming male infertility donor
sperm is now rarely used for fertilization failure. But IVF
with donor oocytes (“egg donation”) is highly
effective at overcoming infertility related to poor egg quality
or decreased ovarian reserve.
The
dramatic rise in pregnancy rates for IVF has been associated
with a trend away from extensive diagnostic testing and toward
earlier utilization of empiric treatment. Women with decreased
ovarian reserve or advanced age (beyond the early 30s) should
be encouraged to consider aggressive treatment early on.
Those wishing to avoid aggressive treatment if possible may
benefit from a more thorough diagnostic evaluation. Because
a significant number of couples with unexplained infertility
will conceive on their own over time, some may reasonably
choose to continue trying on their own a bit longer when
no problem is found. And as with all infertility, psychological
counseling may be helpful, especially in dealing with the
added uncertainty associated with the label “unexplained.”
|